GlassScriptPhysician profile
Rodolfo A Herrera
NPI 1154524668
$19,460.46
in general payments reported to CMS, 2019-2025
53 companies · $2,508 in 2025
The $2,508 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $12K · 2021: $923 · 2022: $1,200 · 2023: $1,976 · 2024: $969 · 2025: $2,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,754 · Travel and Lodging: $1,560 · Education: $104 · Entertainment: $19.04 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,753.82 |
| Travel and Lodging | $1,560.25 |
| Education | $104.35 |
| Entertainment | $19.04 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,040.00 | 2020 | |
| Spinal Simplicity, LLC | $1,431.91 | 2024-2025 | Ha Minuteman G3-R, Patriot Si, Liberty Si |
| Abbott Laboratories | $1,206.03 | 2019-2025 | Octrode, Eterna, Proclaim |
| Genesys Orthopedics Systems, L.L.C. | $770.40 | 2023 | Sacroiliac Joint Fusion System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $707.42 | 2020-2025 | Relistor |
| Abbvie INC. | $676.92 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $396.79 | 2020-2025 | |
| Forte Bio-Pharma LLC | $289.01 | 2021-2023 | Prolate, Nalocet |
| Medtronic, INC. | $282.65 | 2021-2023 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $261.97 | 2021-2025 | Belbuca |
| Curonix LLC | $216.46 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Merz North America, INC. | $200.00 | 2019 | |
| Averitas Pharma INC. | $154.33 | 2024-2025 | Qutenza |
| Si-Bone, INC. | $153.29 | 2020-2025 | |
| Medtronic USA, INC. | $151.98 | 2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $122.98 | 2024-2025 | |
| Hikma Pharmaceuticals USA | $113.75 | 2022-2023 | Kloxxado |
| Novo Nordisk INC | $102.86 | 2025 | Wegovy, Rybelsus, Ozempic |
| Horizon Therapeutics Plc | $85.45 | 2020-2022 | |
| Vertiflex, INC. | $83.57 | 2019 | |
| Azurity Pharmaceuticals, INC. | $67.10 | 2024-2025 | Horizant, Edarbyclor |
| Ibsa Pharma INC. | $59.07 | 2023-2024 | Tirosint, Licart, Tirosint |
| Teva Pharmaceuticals USA, INC. | $58.37 | 2022 | |
| Genzyme Corporation | $57.94 | 2025 | |
| Arbor Pharmaceuticals, INC. | $57.87 | 2021 | |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Lucid Diagnostics INC. | $49.83 | 2022-2023 | |
| Boston Scientific Corporation | $48.92 | 2022-2025 | General - Pain Management |
| Otsuka America Pharmaceutical, INC. | $46.34 | 2025 | Rexulti |
| Jazz Pharmaceuticals INC. | $43.37 | 2021 | |
| Xeris Pharmaceuticals, INC. | $41.55 | 2022-2025 | Gvoke Hypopen |
| Pfizer INC. | $39.03 | 2021 | |
| Nalu Medical, INC. | $37.69 | 2025 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $37.00 | 2023 | Triluron, Hymovis |
| Lilly USA, LLC | $32.98 | 2021-2024 | Zepbound, Mounjaro |
| Lundbeck LLC | $32.21 | 2022-2025 | Rexulti |
| Nevro Corp. | $23.11 | 2021 | |
| Protega Pharmaceutials INC | $22.73 | 2025 | Roxybond |
| Philips North America LLC | $22.61 | 2024 | (Ck7) Extended Holter |
| Exact Sciences Corporation | $21.78 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $20.12 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.77 | 2025 | Trintellix |
| Optos, INC. | $19.04 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Almatica Pharma LLC | $18.48 | 2021 | |
| Inspire Medical Systems, INC. | $16.04 | 2023 | Inspire |
| Dexcom, INC. | $15.28 | 2025 | Dexcom G6 Transmitter |
| Ascensia Diabetes Care US INC. | $15.23 | 2025 | |
| Electronic Waveform Lab, INC. | $13.23 | 2022 | |
| Biodelivery Sciences International, INC. | $12.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.18 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.